We used two tumour markers validated in the cell line-derived EVs: EpCAM, which has been described in EVs from epithelial cells and has been widely used as an epithelial cancer marker in blood (e.g., in Circulating Tumour Cells). Here, EPCAM is linked to neoplasm.